BIOMAT Database Logo BIOMAT Database Logo

Treatment of angina pectoris with dipyridamole: a long-term double blind study. 1967

M Wirecki

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias

Related Publications

M Wirecki
Treatment of angina pectoris with dipyridamole: a double-blind study.
March 1970, Journal of the American Geriatrics Society,
M Wirecki
Dipyridamole in the treatment of angina pectoris. A double-blind evaluation.
September 1967, JAMA,
M Wirecki
[Efficacy of lidoflazine in angina pectoris. A long-term double-blind study].
January 1976, Medizinische Klinik,
M Wirecki
LONG TERM DIPYRIDAMOLE THERAPY OF ANGINA PECTORIS.
August 1965, The American journal of cardiology,
M Wirecki
Treatment of angina pectoris; a double blind study.
December 1955, American practitioner and digest of treatment,
M Wirecki
Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
October 2001, European heart journal,
M Wirecki
[Treatment of angina pectoris with stenoptin. Placebo controlled double-blind study].
September 1979, ZFA. Zeitschrift fur Allgemeinmedizin,
M Wirecki
[Oxyfedrin in long term therapy of angina pectoris (double blind test with cross over)].
January 1972, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete,
M Wirecki
Sotalol in angina pectoris. A double-blind study.
March 1976, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M Wirecki
Iproniazid in angina pectoris; a double-blind study.
July 1959, Circulation,
Copied contents to your clipboard!